First in vivo evidence of microRNA-induced fragile X mental retardation syndrome.
Lin
S-L
SL
Chang
S-Je
SJ
Ying
S-Y
SY
D020121:5' Untranslated Regions / Q000235:genetics; D000818:Animals; D030801:Animals, Genetically Modified; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation; D004195:Disease Models, Animal; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics*; D005600:Fragile X Syndrome / Q000235:genetics*; D005813:Genes, Synthetic; D006801:Humans; D036881:Long-Term Synaptic Depression / Q000235:genetics; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D034622:RNA Interference; D016601:RNA-Binding Proteins / Q000235:genetics* / Q000502:physiology; D043244:Ribonuclease III / Q000378:metabolism; D015027:Zebrafish / Q000235:genetics*; D029961:Zebrafish Proteins / Q000172:deficiency / Q000235:genetics* / Q000502:physiology
D020121:5' Untranslated Regions; D051860:Fragile X Messenger Ribonucleoprotein 1; D035683:MicroRNAs; D016601:RNA-Binding Proteins; D043244:Ribonuclease III; D029961:Zebrafish Proteins; C497683:FMR1 protein, human; C514430:Fmr1 protein, zebrafish